Higher accuracy of self-monitoring of blood glucose in insulin-treated patients in Germany: Clinical and economical aspects

Journal of Diabetes Science and Technology

Volumn 7, Issue 4, 2013, Pages 904-912

  Schnell, Oliver ^a   Erbach, Michael ^b   Wintergerst, Eva ^c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b Sciarc Institut   (Germany)

^c Bayer Healthcare Diabetes Care   (Switzerland)

Author keywords

Accuracy; Cost analysis; Diabetes; Hypoglycemia; Self monitoring of blood glucose

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR DISEASE; COMPUTER SIMULATION; COST BENEFIT ANALYSIS; COST CONTROL; DIABETIC PATIENT; EMERGENCY TREATMENT; FEMALE; GERMANY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE COST; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; MEASUREMENT ERROR; TEST STRIP; BLOOD; DIABETES MELLITUS; ECONOMICS; EQUIPMENT; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICS; TREATMENT OUTCOME; ANALYSIS; DEVICES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; PROCEDURES; STATISTICS AND NUMERICAL DATA;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; COST SAVINGS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; FEMALE; GERMANY; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INSULIN; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84896701306     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681300700413     Document Type: Article

References (61)

1. American Diabetes Association. Standards of medical care in diabetes - 2012. Diabetes Care. 2012;35 Suppl 1:S11-63.
2. Kovatchev BP, Otto E, Cox D, Gonder-Frederick L, Clarke W. Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care. 2006;29(11):2433-8. (Pubitemid 44912248)
3. Schnell O, Alawi H, Battelino T, Ceriello A, Diem P, Felton A, Grzeszczak W, Harno K, Kempler P, Satman I, Vergès B. Consensus statement on self-monitoring of blood glucose in diabetes: a European perspective. Diabetes Stoffwechsel Herz. 2009;18(4):285-9.
4. Peel E, Parry O, Douglas M, Lawton J. Blood glucose self-monitoring in non-insulin-treated type 2 diabetes: a qualitative study of patients' perspectives. Br J Gen Pract. 2004;54(500):183-8. (Pubitemid 38279488)
5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837-53.
6. ACCORD Study Group, Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575-85.
7. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560-72.
8. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129-39.
9. Polonsky WH, Fisher L, Schikman CH, Hinnen DA, Parkin CG, Jelsovsky Z, Petersen B, Schweitzer M, Wagner RS. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care. 2011;34(2):262-7.
10. Franciosi M, Lucisano G, Pellegrini F, Cantarello A, Consoli A, Cucco L, Ghidelli R, Sartore G, Sciangula L, Nicolucci A; ROSES Study Group. ROSES: role of self-monitoring of blood glucose and intensive education in patients with type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabet Med. 2011;28(7):789-96.
11. Durán A, Martín P, Runkle I, Pérez N, Abad R, Fernández M, Del Valle L, Sanz MF, Calle-Pascual AL. Benefits of self-monitoring blood glucose in the management of new-onset type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups. J Diabetes. 2010;2(3):203-11.
12. Tengblad A, Grodzinsky E, Lindstrom K, Molstad S, Borgquist L, Ostgren CJ. Self-monitoring of blood glucose and glycaemic control in type 2 diabetes. Scand J Prim Health Care. 2007;25(3):140-6. (Pubitemid 47396415)
13. Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, Holman R, Kinmonth AL, Neil A. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ. 2007;335(7611):132.
14. Simon J, Gray A, Clarke P, Wade A, Neil A, Farmer A; Diabetes Glycaemic Education and Monitoring Trial Group. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. BMJ. 2008;336(7654):1177-80. (Pubitemid 351809279)
15. International Organization for Standardization. In vitro diagnostic test systems - requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. ISO 15197:2003. http://www.iso.org/iso/home/store/ catalogue-tc/catalogue-detail.htm?csnumber=26309.
16. International Organization for Standardization. In vitro diagnostic test systems - requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. ISO 15197. http://www.iso.org/iso/home/store/ catalogue-tc/catalogue-detail.htm?csnumber=54976.
17. Breton MD, Kovatchev BP. Impact of blood glucose self-monitoring errors on glucose variability, risk for hypoglycemia, and average glucose control in type 1 diabetes: an in silico study. J Diabetes Sci Technol. 2010;4(3):562-70.
18. Heidemann C, Du Y, Scheidt-Nave C. Diabetes mellitus in Germany. GBE kompakt. Berlin: Robert Koch Institute; 2011.
19. DiabetesIDE. Deutscher Gesundheitsbericht Diabetes. Mainz: Kirchheim + Co. GmbH; 2012.
20. Koster I, Huppertz E, Hauner H, Schubert I. Direct costs of diabetes mellitus in Germany - CoDiM 2000-2007. Exp Clin Endocrinol Diabetes. 2011;119(6):377-85.
21. Diabetes Research in Children Network (DirecNet) Study Group. Relative accuracy of the BD Logic and FreeStyle blood glucose meters. Diabetes Technol Ther. 2007;9(2):165-8.
22. Fendler W, Hogendorf A, Szadkowska A, Mlynarski W. Non-coding glucometers among pediatric patients with diabetes: looking for the target population and an accuracy evaluation of no-coding personal glucometer. Pediatr Endocrinol Diabetes Metab. 2011;17(2):57-63.
23. Frank J, Wallace JF, Pardo S, Parkes JL. Performance of the CONTOUR® TS Blood Glucose Monitoring System. J Diabetes Sci Technol. 2011;5(1):198-205.
24. Freckmann G, Baumstark A, Jendrike N, Zschornack E, Kocher S, Tshiananga J, Heister F, Haug C. System accuracy evaluation of 27 blood glucose monitoring systems according to DIN EN ISO 15197. Diabetes Technol Ther. 2010;12(3):221-31.
25. Hsu CT, Hsiao HC, Lee MS, Chang SF, Lee TC, Tsai YS, Zen JM. Assessing the quality of Bionime self-monitoring blood glucose system Rightest GM110: a critical evaluation of interference and ambient circumstances. Clin Chim Acta. 2009;402(1-2):119-23.
26. Kipnes MS, Joseph H, Morris H, Manko J, Bell DE. Clinical performance of the TRUE2go blood glucose system - a novel integrated system for meter and strips. Diabetes Technol Ther. 2009;11(10):649-55.
27. Kuo CY, Hsu CT, Ho CS, Su TE, Wu MH, Wang CJ. Accuracy and precision evaluation of seven self-monitoring blood glucose systems. Diabetes Technol Ther. 2011;13(5):596-600.
28. Lippi G, Salvagno GL, Guidi GC, Negri M, Rizzotti P. Evaluation of four portable self-monitoring blood glucose meters. Ann Clin Biochem. 2006;43(Pt 5):408-13. (Pubitemid 44526542)
29. Solnica B, Kusnierz-Cabala B, Slowinska-Solnica K, Witek P, Cempa A, Malecki MT. Evaluation of the analytical performance of the coulometrybased optium omega blood glucose meter. J Diabetes Sci Technol. 2011;5(6):1612-7.
30. Boren SA, Clarke WL. Analytical and clinical performance of blood glucose monitors. J Diabetes Sci Technol. 2010;4(1):84-97.
31. Dalla Man C, Raimondo DM, Rizza RA, Cobelli C. GIM, simulation software of meal glucose-insulin model. J Diabetes Sci Technol. 2007;1(3):323-30.
32. Dalla Man C, Rizza RA, Cobelli C. Meal simulation model of the glucose-insulin system. IEEE Trans Biomed Eng. 2007;54(10):1740-9. (Pubitemid 47450539)
33. Kovatchev BP, Breton M, Man CD, Cobelli C. In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol. 2009;3(1):44-55.
34. Magni L, Raimondo DM, Bossi L, Man CD, De Nicolao G, Kovatchev B, Cobelli C. Model predictive control of type 1 diabetes: an in silico trial. J Diabetes Sci Technol. 2007;1(6):804-12.
35. Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia. 2002;45(7):937-48. (Pubitemid 34762188)
36. Cryer PE. The pathophysiology of hypoglycaemia in diabetes. Diabetes Nutr Metab. 2002;15(5):330-3. (Pubitemid 36267038)
37. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473-8.
38. UKPDS Risk Engine: http://www.dtu.ox.ac.uk/riskengine/.
39. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes. 1997;46(2):271-86.
40. Bragd J, Adamson U, Lins PE, Wredling R, Oskarsson P. A repeated cross-sectional survey of severe hypoglycaemia in 178 type 1 diabetes mellitus patients performed in 1984 and 1998. Diabet Med. 2003;20(3):216-9. (Pubitemid 36390737)
41. Bott S, Bott U, Berger M, Muhlhauser I. Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia. 1997;40(8):926-32. (Pubitemid 27316573)
42. Müller UA, Femerling M, Reinauer KM, Risse A, Voss M, Jörgens V, Berger M, Mühlhauser I. Intensified treatment and education of type 1 diabetes as clinical routine. A nationwide quality-circle experience in Germany. ASD (the Working Group on Structured Diabetes Therapy of the German Diabetes Association). Diabetes Care. 1999;22 Suppl 2:B29-34. (Pubitemid 29107145)
43. Schiel R, Muller UA. Structured treatment and teaching programs and an improvement in private health care lead to a better quality of diabetes care. JEVIN, a population-based trial 1989/90 up to 1999/2000. Med Klin (Munich). 2003;98(6):303-12. (Pubitemid 36806746)
44. Leese GP, Wang J, Broomhall J, Kelly P, Marsden A, Morrison W, Frier BM, Morris AD; DARTS/MEMO Collaboration. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care. 2003;26(4):1176-80. (Pubitemid 36929268)
45. Farmer AJ, Brockbank KJ, Keech ML, England EJ, Deakin CD. Incidence and costs of severe hypoglycaemia requiring attendance by the emergency medical services in South Central England. Diabet Med. 2012;29(11):1447-50.
46. Bayerische Staatskanzlei. Bayerisches Rettungsdienstgesetz (BayRDG). http://www.gesetze-bayern.de/jportal/portal/page/bsbayprod.psml?showdoccase= 1&doc.id=jlr-RettDGBY2008rahmen&doc.part=X&doc.origin=bs.
47. G-DRG Fallpauschalen-Katalog 2012. http://www.g-drg.de/cms/G-DRG-System- 2012/Fallpauschalen-Katalog/Fallpauschalen-Katalog-2012.
48. vdek. Landesweite Basisfallwerte. http://www.vdek.com/vertragspartner/ Krankenhaeuser/DRG/landesbasisfallwerte/1-lbfw-2012-mit-Tarifrate.pdf.
49. Hamm CW. Guidelines: acute coronary syndrome (ACS). II: acute coronary syndrome with ST-elevation. Z Kardiol. 2004;93(4):324-41. (Pubitemid 38568145)
50. Bruckenberger E. Multidisciplinary health report on cardiology and cardiac surgery. ISBN 978-3-00-032101-6; 2009.
51. Liebl A, Neiss A, Spannheimer A, Reitberger U, Wieseler B, Stammer H, Goertz A. Complications, co-morbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany - results from the CODE-2 study. Exp Clin Endocrinol Diabetes. 2002;110(1):10-6. (Pubitemid 34136276)
52. Roehnisch JU, Behrens S, Maier B. Influence of guideline-based treatment in myocardial infarction patiens with and without diabetes mellitus. Dtsch Aerztebl. 2007;104(40):A2724-9. (Pubitemid 350032317)
53. Koster I, von Ferber L, Ihle P, Schubert I, Hauner H. The cost burden of diabetes mellitus: the evidence from Germany - the CoDiM study. Diabetologia. 2006;49(7):1498-504. (Pubitemid 43848085)
54. Kanavos P, van den Aardweg S, Schurer W. Diabetes expenditure, burden of disease and management in 5 EU countries. London: London School of Economics; 2012. http://www2.lse.ac.uk/LSEHealthAndSocialCare/research/LSEHealth/MTRG/ LSEDiabetesReport26Jan2012.pdf.
55. Schnell O, Amann-Zalan I, Jelsovsky Z, Moritz A, Bermejo JL, Parkin CG, Schweitzer MA, Fisher L, Polonsky WH. Changes in A1C levels are significantly associated with changes in levels of the cardiovascular risk biomarker hs-CRP: results from SteP Study. Diabetes Care. 2013. Epub ahead of print.
56. Klonoff DC, Blonde L, Cembrowski G, Chacra AR, Charpentier G, Colagiuri S, Dailey G, Gabbay RA, Heinemann L, Kerr D, Nicolucci A, Polonsky W, Schnell O, Vigersky R, Yale JF; Coalition for Clinical Research-Self-Monitoring of Blood Glucose Scientific Board. Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes. J Diabetes Sci Technol. 2011;5(6):1529-48.
57. Schnell O, Alawi H, Battelino T, Ceriello A, Diem P, Felton A, Grzeszczak W, Harno K, Kempler P, Satman I, Vergès B. Addressing schemes of self-monitoring of blood glucose in type 2 diabetes: a European perspective and expert recommendation. Diabetes Technol Ther. 2011;13(9):959-65.
58. International Diabetes Federation. Global guideline for type 2 diabetes (2005). http://www.idf.org/global-guideline-type-2-diabetes-2005.
59. Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WA, Bouter LM. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care. 2005;28(6):1510-7. (Pubitemid 40756728)
60. Malanda UL, Welschen LM, Riphagen II, Dekker JM, Nijpels G, Bot SD. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev. 2012;1:CD005060.
61. Schnell O, Alawi H, Battelino T, Ceriello A, Diem P, Felton A, Grzeszczak W, Harno K, Hummel M, Kempler P, Satman I, Vergès B. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin: letter to the editor. Cochrane Database Syst Rev. 2012;1:CD005060